Suchergebnisse - "Dillen, Lieve"

PubPharm (99)

1

Absolute quantitation of binding antibodies from clinical samples

enthalten in: NPJ vaccines | 2024

von Tang, C. | Verwilligen, A. | Sadoff, J. | +15

2

IP-LC-MSMS Enables Identification of Three Tau O-GlcNAcylation Sites as O-GlcNAcase Inhibition Pharmacodynamic Readout in Transgenic Mice Overexpressing Human Tau

enthalten in: Journal of proteome research | 2023

von Bijttebier, S. | Rodrigues Martins, D. | Mertens, L. | +8

3

2021 White Paper on Recent Issues in Bioanalysis : Mass Spec of Proteins, Extracellular Vesicles, CRISPR, Chiral Assays, Oligos; Nanomedicines Bioanalysis; ICH M10 Section 7.1; Non-Liquid & Rare Matrices; Regulatory Inputs (

enthalten in: Bioanalysis | 2022

von Kaur, S. | Alley, S. | Szapacs, M. | +74

4

Correction to : Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug-Drug Interactions

enthalten in: Clinical pharmacokinetics | 2022

von Willemin, M. | Van Der Made, T. | Pijpers, I. | +11

ErratumFor: Clin Pharmacokinet. 2021 Sep;60(9):1187-1199. - PMID 33840062

5

Correction to: Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug–Drug Interactions

enthalten in: Clinical pharmacokinetics | 2022

von Willemin, M. | Van Der Made, T. | Pijpers, I. | +11

6

Correction to: Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug–Drug Interactions

enthalten in: Clinical pharmacokinetics | 2022

von Willemin, M. | Van Der Made, T. | Pijpers, I. | +11

7

Correction to: Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug–Drug Interactions

enthalten in: Clinical pharmacokinetics | 2022

von Willemin, M. | Van Der Made, T. | Pijpers, I. | +11

8

2021 White Paper on Recent Issues in Bioanalysis: Mass Spec of Proteins, Extracellular Vesicles, CRISPR, Chiral Assays, Oligos; Nanomedicines Bioanalysis; ICH M10 Section 7.1; Non-Liquid & Rare Matrices; Regulatory Inputs (Part 1A– Recommendations on Endogenous Compounds, Small Molecules, Complex Methods, Regulated Mass Spec of Large Molecules, Small Molecule, PoC & Part 1B- Regulatory Agencies' Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine)

enthalten in: Bioanalysis | 2022

von Kaur, S. | Alley, S. | Szapacs, M. | +74

9

Multimodal biomarker discovery for active Onchocerca volvulus infection

enthalten in: PLoS neglected tropical diseases | 2021

von Lagatie, O. | Njumbe Ediage, E. | Van Roosbroeck, D. | +13

10

Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug-Drug Interactions

enthalten in: Clinical pharmacokinetics | 2021

von Willemin, M. | Van Der Made, T. | Pijpers, I. | +11

ErratumIn: Clin Pharmacokinet. 2022 Mar;61(3):463. - PMID 35175504

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]